Back to Results
First PageMeta Content
Organofluorides / Diflunisal / Polyneuropathy / Chemistry / Biology / Neurological disorders / Tafamidis / Transthyretin / Neurology


Document Date: 2015-04-21 05:43:05

Open Document

File Size: 496,71 KB

Share Result on Facebook

Company

Pfizer / BP / Alnylam Pharmaceuticals Inc. / /

Currency

ILS / /

Event

FDA Phase / /

MedicalCondition

Polyneuropathy / osteonecrosis / lower limb venous thrombosis / Moderate Infusion site irritation / Severity Flushing / disease / Moderate Neuralgia / e.g. disease / Mild Diarrhea / Mild Alopecia / Familial Amyloidotic Polyneuropathy / renal failure / dominant hereditary amyloidosis / Moderate Fatigue / Mild Ectropion / Patisiran Familial Amyloidotic Polyneuropathy / Mild Insomnia / early-stage disease / dehydration / /

MedicalTreatment

Liver transplant / /

Organization

National Institute of Health / European Union / /

Person

Van Nes / Mayo Clin Proc / /

Product

Diflunisal / Vyndaqel / FAP / Patisiran An Investigational / W1 / NIH-sponsored / Vyndaqel® (tafamidis) / /

Technology

genotype / siRNA / /

SocialTag